61 – 70 of 363
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Survey among experts on the future role of tau-PET in clinical practice and trials
- Contribution to journal › Article
-
Mark
Cerebrovascular disease is associated with Alzheimer's plasma biomarker concentrations in adults with Down syndrome
- Contribution to journal › Article
-
Mark
AβPP-tau-HAS1 axis trigger HAS1-related nuclear speckles and gene transcription in Alzheimer's disease
- Contribution to journal › Article
- 2023
-
Mark
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer's disease
- Contribution to journal › Article
-
Mark
Clinical performance and robustness evaluation of plasma amyloid-β42/40 prescreening
- Contribution to journal › Article
-
Mark
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease
- Contribution to journal › Article
-
Mark
CSF ferritin in the clinicopathological progression of Alzheimer's disease and associations with APOE and inflammation biomarkers
- Contribution to journal › Article
-
Mark
Robustness of CSF Aβ42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes
- Contribution to journal › Article
-
Mark
Neuroinflammation and amyloid-β in early Alzheimer’s disease. Insight into the earliest events using mouse models
(2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Genetically identical twin-pair difference models support the amyloid cascade hypothesis
- Contribution to journal › Article
